Stanford University
Showing 51-100 of 14,400 Results
-
Emma Adair
Clinical Research Manager, Anesthesia - Adult Pain Medicine
Current Role at StanfordEmma manages the Neurology & Neurosurgery Clinical Trials Team consisting of 17 Clinical Research Coordinators conducting 70+ clinical trials in areas including: Device Neurosurgery, Functional Neurosurgery, Headache, Epilepsy, Neuroimmunology, Alzheimers/Memory Disorders, Parkinson's, Radiology, and Bio Banks.
-
Maheen Mausoof Adamson
Clinical Professor (Affiliated), Neurosurgery
Staff, Neurosurgery OperationsBioDr. Maheen Mausoof Adamson is a Clinical Professor of Neurosurgery (Affiliated) at Stanford School of Medicine, Director of Research for Women's Operational Military Exposure Network Center of Excellence (WOMENCOE), and Senior Scientist for Rehabilitation Services at VA Palo Alto Healthcare System. Adamson completed her undergraduate degrees in neurobiology and women's studies at the University of California, Irvine. She completed her Ph.D. in neuroscience from the University of Southern California and a postdoctoral fellowship in Psychiatry and Behavioral Sciences at Stanford School of Medicine. She also has a Masters in Healthcare Leadership from the School of Public Health from Brown University and is a faculty fellow for Stanford Byers Biodesign Program.
Dr. Adamson’s expertise and interests span employing translational neuroscience methodologies for diagnostic and neuromodulation treatments (such as repetitive Transcranial Magnetic Stimulation (rTMS)) for frequent health problems in patients with Traumatic Brain Injury (TBI), psychiatric problems, and Alzheimer's disease. She has employed advanced structural and functional imaging modalities and biomarker assessments for treatment response and diagnosis in Veteran, active military, and civilian populations with these health problems. She has been a leader in identifying sex differences in brain injury, particularly in the Veteran population. She currently serves as PI and Site-PI on numerous neuromodulation clinical trials and collaborates internationally to develop advanced diagnostic methods in neuroimaging, especially in underserved communities. As Director of the Adamson Lab, she is actively involved in translating research, such as neuromodulation and virtual and augmented reality, into clinical settings.
In her new role as Research Director of WOMENCOE, she is developing the research and education center to investigate and disseminate findings on the impact of military environmental exposure on reproductive health, cancer, psychiatric illness, cognitive decline, and other women's health issues. This network is funded by the VA Health Outcomes Military Exposure Center under Department of Veterans Affairs
Dr. Adamson is also the lead PI of ENIGMA-PAK study that aims to Leverage Consanguinity in Pakistan to Uncover the Genomic Architecture of Alzheimer's Disease. She has received recognition in national and international settings and serves on several editorial and industry advisory boards. She is also CEO and founder of her digital health startup Soof Solutions Inc which uses eye tracking for communication in individuals lacking the power of speech. She is also intricately involved in mentoring postdoctoral fellows, residents, undergraduates and high school students in STEM careers. -
Sophia Adelson
Rsch Data Analyst 2, Pediatrics - Genetics
BioSophia Adelson is a Research Genetic Counselor in the Department of Pediatrics, Division of Genetics at Stanford University. Her work focuses on advancing reproductive genetics and improving maternal and childhood health outcomes through clinical research and thoughtful implementation of genomic technologies. Sophia’s interest in reproductive health began during her undergraduate studies at Wellesley College, a historically women’s college that shaped her strong commitment to maternal health and reproductive justice. This foundation continues to guide her work, which centers on advancing equitable, evidence-based care for pregnant individuals, newborns, and children.
At Stanford, Sophia works closely with Dr. Christina Tise on several research initiatives at the intersection of reproductive and pediatric genetics. She contributes to the BabySeq Project, a study using genome sequencing to identify actionable genetic risks in newborns, where she coordinates IRB submissions, pediatrician engagement, family recruitment and consent, and the return of results. Sophia also plays an active role in the TRIOS Study, which investigates the genetic causes of recurrent pregnancy loss. Her work explores participants’ experiences receiving genomic results and aims to improve counseling practices and outcomes for families navigating reproductive challenges. In addition, Sophia contributes to the GREGoR Consortium (Genomics Research to Elucidate the Genetics of Rare diseases), supporting efforts to identify novel disease genes and improve diagnostic yield for individuals with rare, undiagnosed conditions.
Sophia’s research and clinical interests include reproductive and prenatal genetics, rare disease genomics, bioethics, and equitable implementation of genomic medicine. She is passionate about proactive healthcare and advocating for effective health risk communication within families, with the goal of improving understanding, decision-making, and health outcomes across diverse populations.
Research interests: reproductive genetics, prenatal genetics, recurrent pregnancy loss, newborn genomic screening, rare disease genomics, bioethics, proactive healthcare, family health communication, equitable implementation of genomics
